Alzheimer's & Dementia News and Research

Latest Alzheimer's & Dementia News and Research

Receiving general anesthesia not associated with dementia in elderly patients, research finds

Elderly patients who receive anesthesia are no more likely to develop long-term dementia or Alzheimer's disease than other seniors, according to new Mayo Clinic research.

2 May 2013

UAB study suggests Mediterranean diet may be linked to preserving memory, thinking abilities

A University of Alabama at Birmingham study suggests that the Mediterranean diet, which urges consuming foods that contain omega-3 fatty acids found in fish, chicken and salad dressing, and avoiding saturated fats, meat and dairy foods, may be linked to preserving memory and thinking abilities.

30 Apr 2013

UCSF study focuses on vexing problems of handling skin cancers among elderly patients

Surgery is often recommended for skin cancers, but older, sicker patients can endure complications as a result and may not live long enough to benefit from the treatment.

30 Apr 2013

Researchers identify how a defective protein plays central role in Giant Axonal Neuropathy

A team of international researchers led by Northwestern Medicine scientists has identified how a defective protein plays a central role in a rare, lethal childhood disease known as Giant Axonal Neuropathy, or GAN.

29 Apr 2013

Revised criteria improve early-onset dementia diagnosis

Updated diagnostic criteria based on the Frontotemporal Dementia Consensus are “encouragingly” sensitive and specific in identifying patients who have early-onset dementia, a study finds.

29 Apr 2013

Opsona raises €33M in oversubscribed financing round

Opsona Therapeutics Limited, the innate immune drug development company, today announced that it has raised €33 million (US $ 43 million) in an oversubscribed Series C financing.

29 Apr 2013

UK’s health performance: an interview with Prof. Murray, University of Washington

Rates of premature mortality in the UK have been falling steadily, but the pace of decline is not as fast as in many other high-income countries, such as Australia. In that sense, the UK lags behind.

29 Apr 2013

Intermittent fasting: A path to weight loss and improved cardiovascular risk

Intermittent fasting is all the rage, but scientific evidence showing how such regimes affect human health is not always clear cut. Now a scientific review in the British Journal of Diabetes and Vascular Disease published by SAGE, suggests that fasting diets may help those with diabetes and cardiovascular disease, alongside established weight loss claims.

29 Apr 2013

New treatment strategy for patients with CMT disease on the horizon

A potential new treatment strategy for patients with Charcot-Marie-Tooth disease is on the horizon, thanks to research by neuroscientists now at the University at Buffalo's Hunter James Kelly Research Institute and their colleagues in Italy and England.

29 Apr 2013

CHMP recommends approval of NUEDEXTA for treatment of pseudobulbar affect

Avanir Pharmaceuticals, Inc. today announced that the Committee for Medicinal Products for Human Use of the European Medicines Agency has adopted a positive opinion for NUEDEXTA (dextromethorphan hydrobromide and quinidine sulfate), recommending NUEDEXTA be approved for the treatment of pseudobulbar affect, irrespective of neurologic cause.

29 Apr 2013

JHUSON opens registration for first-ever MOOC

Prospective students, lifelong learners, or anyone simply interested in patient safety can get a thorough overview of the topic and a taste of the Johns Hopkins educational experience beginning June 3.

29 Apr 2013

Researchers create "designer" tracer for earlier diagnosis and better treatments of Alzheimer's

One of the biggest challenges with Alzheimer's disease (AD) is that by the time physicians can detect behavioral changes, the disease has already begun its irreversibly destructive course.

26 Apr 2013

Network of genes is a crucial mechanism driving Late Onset Alzheimer's Disease

Scientists from the Icahn School of Medicine at Mount Sinai, in collaboration with researchers from Icelandic Heart Association, Sage Bionetworks, and other institutions, have discovered that a network of genes involved in the inflammatory response in the brain is a crucial mechanism driving Late Onset Alzheimer's Disease (LOAD).

26 Apr 2013

Neuralstem gets approval from FDA for dosing cohort patients in NSI-189 Phase Ib in MDD treatment

Neuralstem, Inc. announced that it has received approval from the Food and Drug Administration (FDA) to begin dosing the third and final cohort of patients in its ongoing Phase Ib to test the safety of NSI-189 in the treatment of major depressive disorder (MDD).

26 Apr 2013

Rexceptor receives exclusive license for novel treatment of Alzheimer's disease

Case Western Reserve's Technology Transfer Office has granted an exclusive license of a novel Alzheimer's Disease (AD) treatment strategy to spinoff company ReXceptor Inc., which plans to initiate early-stage human clinical trials of the medication within the next few months.

26 Apr 2013

Warning over US neurologist shortage

Neurologists are urging the US Congress to undertake policy changes that will encourage more medical residents to specialize in neurology to ensure patient access to care.

25 Apr 2013

Research reveals that molecular madness goes on in the brain after blast exposure

A multicenter study led by scientists at the University of Pittsburgh School of Medicine shows that mild traumatic brain injury after blast exposure produces inflammation, oxidative stress and gene activation patterns akin to disorders of memory processing such as Alzheimer's disease.

25 Apr 2013

Researchers studying lipids to learn more about normal, abnormal biology

When you have your cholesterol checked, the doctor typically gives you levels of three fats found in the blood: LDL, HDL and triglycerides. But did you know your body contains thousands of other types of fats, or lipids?

24 Apr 2013

Investigational treatment for ALS passes early phase clinical trial for safety

An investigational treatment for an inherited form of Lou Gehrig's disease has passed an early phase clinical trial for safety, researchers at Washington University School of Medicine in St. Louis and Massachusetts General Hospital report.

24 Apr 2013

PPMI to launch additional study to evaluate multiple potential biomarkers for Parkinson's disease

The Parkinson's Progression Markers Initiative, a landmark biomarker clinical study, has completed enrollment of its initial 600-member cohort of Parkinson's patients and controls, and will launch additional study cohorts to leverage the existing PPMI infrastructure and evaluate multiple potential biomarkers for Parkinson's disease.

24 Apr 2013

Alzheimer's & Dementia News and Research

Latest Alzheimer's & Dementia News and Research

Receiving general anesthesia not associated with dementia in elderly patients, research finds

UAB study suggests Mediterranean diet may be linked to preserving memory, thinking abilities

UCSF study focuses on vexing problems of handling skin cancers among elderly patients

Researchers identify how a defective protein plays central role in Giant Axonal Neuropathy

Revised criteria improve early-onset dementia diagnosis

Opsona raises €33M in oversubscribed financing round

UK’s health performance: an interview with Prof. Murray, University of Washington

Intermittent fasting: A path to weight loss and improved cardiovascular risk

New treatment strategy for patients with CMT disease on the horizon

CHMP recommends approval of NUEDEXTA for treatment of pseudobulbar affect

JHUSON opens registration for first-ever MOOC

Researchers create "designer" tracer for earlier diagnosis and better treatments of Alzheimer's

Network of genes is a crucial mechanism driving Late Onset Alzheimer's Disease

Neuralstem gets approval from FDA for dosing cohort patients in NSI-189 Phase Ib in MDD treatment

Rexceptor receives exclusive license for novel treatment of Alzheimer's disease

Warning over US neurologist shortage

Research reveals that molecular madness goes on in the brain after blast exposure

Researchers studying lipids to learn more about normal, abnormal biology

Investigational treatment for ALS passes early phase clinical trial for safety

PPMI to launch additional study to evaluate multiple potential biomarkers for Parkinson's disease

eBook: Advancing neurodegenerative research with iPSC-derived microglia models eBook

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Alzheimer's & Dementia News and Research

Latest Alzheimer's & Dementia News and Research

eBook: Advancing neurodegenerative research with iPSC-derived microglia models eBook

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Newsletters you may be interested in